Yuanyuan Xiao

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al. · Nature · 2014 · 5.2K citations

Medicine, Biomarker Target, Anti-pd-l1 Antibody Mpdl3280a +10

Abstract 2859: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC)

Leisha A. Emens, Fadi S. Braiteh, Philippe A. Cassier et al. · Cancer Research · 2015 · 210 citations

Breast Oncology, Pd-l1 Expression, Medicine +15

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction

Jing Zhao, Alan J. Blayney, Xiaorong Liu et al. · Nature Communications · 2021 · 152 citations · Full text

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation

Robert B. Jenkins, Yuanyuan Xiao, Hugues Sicotte et al. · Nature Genetics · 2012 · 143 citations · Full text

Low-frequency Variant, Neuro-oncology, Idh2 Mutation +9

Polymorphisms of <i>LIG4, BTBD2, HMGA2</i>, and <i>RTEL1</i> Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma Survival

Yanhong Liu, Sanjay Shete, Carol J. Etzel et al. · Journal of Clinical Oncology · 2010 · 112 citations · Full text